Protection of primary human T cells from HIV infection by Trev: A transdominant fusion gene

Human Gene Therapy

Volumn 8, Issue 7, 1997, Pages 861-868

  Chinen, Javier ^a   Aguilar Cordova, Estuardo ^a   Ng Tang, Derek ^a   Lewis, Dorothy E ^a   Belmont, John W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; HYBRID PROTEIN; MESSENGER RNA; MUTANT PROTEIN; NUCLEAR PROTEIN; REV PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ARTICLE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; GENE EXPRESSION; GENE FUSION; GENE SEQUENCE; GENE THERAPY; GENE TRANSFER; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; LEUKEMIA CELL LINE; PERIPHERAL LYMPHOCYTE; T LYMPHOCYTE; TARGET CELL; VIRUS GENE; VIRUS REPLICATION; VIRUS RESISTANCE;

EID: 0030976238     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.7-861     Document Type: Article

References (25)

1. AGUILAR-CORDOVA, E.C., CHINEN, J., DONEHOWER, L., HARPER, J.W., BUTEL, J.S., and BELMONT, J.W. (1995). Inhibition of HIV-1 by a double transdominant fusion gene. Gene Ther. 2, 181-186.
2. CULLEN, B.R. (1992). Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol. Rev. 56, 375-394.
3. CULLEN, B.R. (1993). An introduction to human retroviruses. In Human Retroviruses, B.R. Cullen, ed. (Oxford University Press, New York).
4. CULLEN, B.R., HAUBER, J., CAMPBELL, K., SODROSKI, J.G., HASELTINE, W.A., and ROSEN, CA. (1988). Subcellular localization of the human immunodeficiency virus trans-acting art gene product. J. Virol 62, 2498-3002.
5. DIGNAM, J.D., LEBOVITZ, R.M., and ROEDER, R.G. (1983). Accurate transcript initiated by RNA pol II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489.
6. ENSOLI, B., BARILLARI, G., SALAHUDDIN, S.Z., GALLO, R.C., and WONG-STAAL, F. (1990). Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 362, 359-362.
7. FOX, B.A., WOFFENDIN, C., YANG, Z.Y., SAN, H., RANGA, U., GORDON, D., OSTERHOLZER, J., and NABEL, G.J. (1995). Genetic modification of human peripheral blood lymphocytes with a transdominant negative form of Rev: Safety and toxicity. Hum. Gene Ther. 6, 997-1004.
8. GUNTHER, K.C., KHAN, A.S., and NOGUCHI, P.D. (1993). (The safety of retroviral vectors. Hum. Gene Ther. 4, 643-645.
9. HOWCROFT, T.K., PALMER, L.A., BROWN, J., RELLAHAN, B., KASHANCHI, F., BRADY, J.N., and SINGER, D.S. (1995). HIV-Tat represses transcription through Sp1-like elements in the basal promoter. Immunity 3, 127-138.
10. JOHNSON, V.A. (1995). Nucleoside reverse transcriptase inhibitors and resistance of human immunodeficiency virus type 1. J. Infect. Dis. 171(Suppl. 2), S140-149.
11. JOHNSTON, M.I., and HOTH, D.F. (1993). Present status and future prospects for HIV therapies. Science 260, 1286-1293.
12. JONES, K.A. (1993). Tat and the HIV-1 promoter. Curr. Opin. Cell Biol. 5, 461-468.
13. KIMPTON, J., and EMERMAN, M. (1992). Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66, 2232-2239.
14. LEAVITT, M.C., YU, M., YAMADA, O., KRAUS, G., LEOREY, D., POESCHLA, E., and WONG-STAAL, F. (1994). Transfer of an anti-HIV-1 ribozyme gene into primary human T lymphocytes. Hum. Gene Ther. 5, 1115-1120.
15. LEVY, JA. (1993). Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57, 183-289.
16. MALIM, M.H., HAUBER, J., FENRICK, R., and CULLEN, B.R. (1988). Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes. Nature 335, 181-183.
17. MALIM, M.H., BOHNLEIN, S., HAUBER, J., and CULLEN, B.R. (1989). Functional dissection of the HIV-1 Rev transactivator. Derivation of a transdominant repressor of Rev function. Cell 58, 205-214.
18. MALIM, M.H., FREIMUTH, W.W., LIU, J., BOYLE, T.J., LYERLY, H.K., CULLEN, B.R., and NABEL, G.J. (1993). Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication. J. Exp. Med. 176, 1197-1201.
19. MMWR. (1994). AIDS Report 1993. MMWR 43, 152-159.
20. MODESTI, N., GARCIA, J., DEBOUCK, C., PETERLIN, M., and GAYNOR, R., (1991). Transdominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression. New Biol. 3, 759-768.
21. MULLIGAN, R.C. (1993). The basic science of gene therapy. Science 260, 926-932.
22. RICHMAN, D.D. (1993). Resistance of clinical isolates to retroviral agents. Antimicrob. Agent Chemother. 37, 1207-1213.
23. VOLBERDING, P.A., LAGAKOS, S.W., GRIMES, J.M., and WONG-STAAL, F. (1991). Human immunodeficiency viruses and their replication. In Fundamental Virology, 2nd ed., B. Fields, ed. (Raven Press, New York).
24. WONG-STAAL, F. (1991). Human immunodeficiency viruses and their replication. In Fundamental Virology, 2nd ed., B. Fields, ed. (Raven Press, New York).
25. YU, M., POESCHLA, E., and WONG-STAAL, F. (1994). Progress towards gene therapy for HIV infection. Gene Ther. 1, 13-26.